<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marchant, G. E.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Small is Beautiful: What Can Nanotechnology Do for Personalized Medicine?</style></title><secondary-title><style face="normal" font="default" size="100%">Current Pharmacogenomics &amp; Personalized Medicine</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">MEDICAL care</style></keyword><keyword><style  face="normal" font="default" size="100%">Medical Devices</style></keyword><keyword><style  face="normal" font="default" size="100%">MEDICINE -- Research</style></keyword><keyword><style  face="normal" font="default" size="100%">MOLECULES</style></keyword><keyword><style  face="normal" font="default" size="100%">Nanomedicine</style></keyword><keyword><style  face="normal" font="default" size="100%">NANOTECHNOLOGY</style></keyword><keyword><style  face="normal" font="default" size="100%">NUCLEOTIDE sequence</style></keyword><keyword><style  face="normal" font="default" size="100%">Pharmaceuticals</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2009</style></year></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">231-237</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">This article describes the scientific and technical opportunities and challenges in applying nanotechnology to personalized medicine,and addresses some of the policy, legal and ethical issues raised by the convergence of these two fields.</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Article</style></work-type><accession-num><style face="normal" font="default" size="100%">47965338</style></accession-num><notes><style face="normal" font="default" size="100%">Marchant, G. E. 1; Email Address: gary.marchant@asu.edu; Affiliation: 1: Center for the Study of Law, Science &amp; Technology, Arizona State University, AZ, USA; Source Info: 2009, Vol. 7 Issue 4, p231; Subject Term: NANOTECHNOLOGY; Subject Term: MEDICINE -- Research; Subject Term: MEDICAL care; Subject Term: NUCLEOTIDE sequence; Subject Term: MOLECULES; Author-Supplied Keyword: Medical Devices; Author-Supplied Keyword: Nanomedicine; Author-Supplied Keyword: Nanotechnology; Author-Supplied Keyword: Pharmaceuticals; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 7p; Document Type: Article</style></notes></record></records></xml>